Velaz L, Ingraham R H, Chalovich J M
Department of Biochemistry, East Carolina University School of Medicine, Greenville, North Carolina 27858.
J Biol Chem. 1990 Feb 15;265(5):2929-34.
We have proposed earlier that caldesmon inhibits the actin-activated ATPase activity of smooth muscle heavy meromyosin (HMM) by inhibiting the binding of the HMM.ATP complex to the productive site of actin (Hemric, M. E., and Chalovich, J. M. (1988) J. Biol. Chem. 263, 1868-1885). This has been difficult to prove directly because caldesmon also binds to HMM and it is difficult to distinguish the actin-caldesmon-HMM complex from the actin-caldesmon complex in binding studies. We have eliminated the interaction between caldesmon and smooth HMM by digestion of caldesmon with chymotrypsin. This cleaved caldesmon inhibits the actin-activated ATPase rate of smooth HMM and this inhibition is correlated with a decrease in the binding of HMM.ATP to actin. Therefore, caldesmon functions by inhibiting the binding of the myosin-ATP complex to actin regardless of the source of myosin. We have also isolated the myosin-binding region of caldesmon and have performed a partial sequence. Comparison of this sequence with the derived sequence of caldesmon demonstrates, unequivocally, that the myosin-binding region of caldesmon begins at the amino terminus and extends beyond the first Cys residue.
我们先前曾提出,钙调蛋白通过抑制重酶解肌球蛋白(HMM).ATP复合物与肌动蛋白活性位点的结合,来抑制平滑肌重酶解肌球蛋白(HMM)的肌动蛋白激活的ATP酶活性(Hemric,M. E.,和Chalovich,J. M.(1988年)《生物化学杂志》263卷,1868 - 1885页)。这很难直接证明,因为钙调蛋白也与HMM结合,并且在结合研究中很难区分肌动蛋白 - 钙调蛋白 - HMM复合物和肌动蛋白 - 钙调蛋白复合物。我们通过用胰凝乳蛋白酶消化钙调蛋白,消除了钙调蛋白与平滑肌HMM之间的相互作用。这种裂解的钙调蛋白抑制平滑肌HMM的肌动蛋白激活的ATP酶速率,并且这种抑制与HMM.ATP与肌动蛋白结合的减少相关。因此,无论肌球蛋白的来源如何,钙调蛋白都通过抑制肌球蛋白 - ATP复合物与肌动蛋白的结合来发挥作用。我们还分离出了钙调蛋白的肌球蛋白结合区域,并进行了部分测序。将该序列与推导的钙调蛋白序列进行比较,明确表明钙调蛋白的肌球蛋白结合区域从氨基末端开始,并延伸到第一个半胱氨酸残基之外。